An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
- Study Title
- An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
- Teva Identifier
- TV48125-CNS-30068 | 2017-002441-30
- ClinicalTrials.gov Identifier
- NCT03308968
- Study Status
- Completed
- Trial Condition(s)
- Migraine Prophylaxis
- Interventions
- Drug: Fremanezumab | Drug: Placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years to 70 Years
- Trial Duration
- October 13, 2017 - May 29, 2019
- Phase
- Phase 3
